Creating advanced tools for designing small molecules to target diseases
Development, Validation, and Application of Structure-based Tools for Computational Molecular Design
This study is working on creating smart computer tools to help design new medicines that can better target proteins involved in diseases like cancer and AIDS, making it easier to develop effective treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University New York Stony Brook NIH-funded |
| Lab location | 1 site (Stony Brook, United States) |
| Project ID | NIH-10841778 on NIH RePORTER |
What this research studies
This research focuses on developing and validating computational tools that help design small organic molecules aimed at specific biological targets, such as proteins involved in diseases like cancer and AIDS. By using atomic-level computational modeling, the researchers aim to understand how molecules interact with their targets, which can lead to more effective drug designs. The project seeks to overcome existing challenges in molecular design by creating innovative software that allows for the intelligent assembly of drug-like compounds tailored to specific proteins. This approach could significantly enhance the efficiency and accuracy of drug development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by diseases that require novel drug therapies, particularly those related to cancer and HIV/AIDS.
Not a fit: Patients with conditions that do not involve the biological targets being studied, or those who are not seeking new drug therapies, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of more effective and targeted treatments for diseases such as cancer and AIDS.
How similar studies have performed: Previous research has shown success in using computational modeling for drug design, indicating that this approach has the potential to yield significant advancements.
Where this research is happening
Stony Brook, United States
- State University New York Stony Brook — Stony Brook, United States (Active)
Researchers
- Principal investigator: Rizzo, Robert C. — State University New York Stony Brook
- Study coordinator: Rizzo, Robert C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.